Literature DB >> 34007020

Exercise training as a modulator of epigenetic events in prostate tumors.

Suzanne Dufresne1, Jordan Guéritat1, Carmen P Wong2,3, Amin Isanejad1, Emily Ho2,3,4, Eva Serna5, Marie-Carmen Gomez-Cabrera5, Amélie Rebillard6.   

Abstract

BACKGROUND: Exercise is increasingly recognized as an effective strategy to improve cancer prevention and prognosis. Several biological mechanisms mediating these benefits have been proposed, but the role of epigenetics remains largely unknown. Since epigenetics is highly susceptible to lifestyle factors, we hypothesized that exercise could affect the epigenome landscape in cancer tissues.
METHODS: Rats implanted with AT1 prostate tumors were randomized to either control or exercise training. microRNA expression, DNA methylation and histone acetylation were analyzed in the tumor tissue.
RESULTS: MiR-27a-5p appeared to be differently expressed between sedentary and trained rats. Furthermore, exercise increased global DNA methylation and decreased DNA methyltransferases mRNA expression in the tumor tissue. Histone acetylation however remained unaltered.
CONCLUSION: Overall, exercise might reverse some of the cancer-related epigenetic alterations in the prostate tumor tissue.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34007020     DOI: 10.1038/s41391-021-00380-x

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  14 in total

Review 1.  Global DNA hypomethylation in prostate cancer development and progression: a systematic review.

Authors:  R Zelic; V Fiano; C Grasso; D Zugna; A Pettersson; A Gillio-Tos; F Merletti; L Richiardi
Journal:  Prostate Cancer Prostatic Dis       Date:  2014-11-11       Impact factor: 5.554

2.  MicroRNA-206, let-7a and microRNA-21 pathways involved in the anti-angiogenesis effects of the interval exercise training and hormone therapy in breast cancer.

Authors:  Amin Isanejad; Ali Mohammad Alizadeh; Sadegh Amani Shalamzari; Hamid Khodayari; Saeed Khodayari; Vahid Khori; Najmeh Khojastehnjad
Journal:  Life Sci       Date:  2016-02-26       Impact factor: 5.037

Review 3.  The importance of DNA methylation in prostate cancer development.

Authors:  Charles E Massie; Ian G Mills; Andy G Lynch
Journal:  J Steroid Biochem Mol Biol       Date:  2016-04-24       Impact factor: 4.292

4.  Exercise training combined with antioxidant supplementation prevents the antiproliferative activity of their single treatment in prostate cancer through inhibition of redox adaptation.

Authors:  Jordan Gueritat; Luz Lefeuvre-Orfila; Sophie Vincent; Armel Cretual; Jean-Luc Ravanat; Arlette Gratas-Delamarche; Françoise Rannou-Bekono; Amélie Rebillard
Journal:  Free Radic Biol Med       Date:  2014-09-16       Impact factor: 7.376

Review 5.  Epigenetic modifications in prostate cancer.

Authors:  Marjolaine Ngollo; Aslihan Dagdemir; Seher Karsli-Ceppioglu; Gaelle Judes; Amaury Pajon; Frederique Penault-Llorca; Jean-Paul Boiteux; Yves-Jean Bignon; Laurent Guy; Dominique J Bernard-Gallon
Journal:  Epigenomics       Date:  2014       Impact factor: 4.778

Review 6.  Epigenetics in prostate cancer: biologic and clinical relevance.

Authors:  Carmen Jerónimo; Patrick J Bastian; Anders Bjartell; Giuseppina M Carbone; James W F Catto; Susan J Clark; Rui Henrique; William G Nelson; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2011-06-22       Impact factor: 20.096

Review 7.  The epigenome as a therapeutic target in prostate cancer.

Authors:  Antoinette S Perry; R William G Watson; Mark Lawler; Donal Hollywood
Journal:  Nat Rev Urol       Date:  2010-11-09       Impact factor: 14.432

8.  DNA methylation status is inversely correlated with green tea intake and physical activity in gastric cancer patients.

Authors:  Yasuhito Yuasa; Hiromi Nagasaki; Yoshimitsu Akiyama; Yutaka Hashimoto; Touichirou Takizawa; Kazuyuki Kojima; Tatsuyuki Kawano; Kenichi Sugihara; Kazue Imai; Kei Nakachi
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

9.  DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.

Authors:  Srinivasan Yegnasubramanian; Michael C Haffner; Yonggang Zhang; Bora Gurel; Toby C Cornish; Zhijin Wu; Rafael A Irizarry; James Morgan; Jessica Hicks; Theodore L DeWeese; William B Isaacs; G Steven Bova; Angelo M De Marzo; William G Nelson
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

Review 10.  Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy.

Authors:  Mankgopo M Kgatle; Asgar A Kalla; Muhammed M Islam; Mike Sathekge; Razia Moorad
Journal:  Prostate Cancer       Date:  2016-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.